REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW 10,510
-220 (-2.05%)
At close: Nov 21, 2025
REYON Pharmaceutical Market Cap
REYON Pharmaceutical has a market cap or net worth of 199.55 billion as of November 26, 2025. Its market cap has decreased by -34.02% in one year.
Market Cap
199.55B
Enterprise Value
405.25B
Revenue
149.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,510.00
Market Cap Chart
Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 199.55B, an increase of 21.27%. That is a compound annual growth rate of 1.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 199.55B | -15.26% |
| Dec 30, 2024 | 235.50B | -22.37% |
| Dec 28, 2023 | 303.36B | -21.07% |
| Dec 29, 2022 | 384.35B | -39.10% |
| Dec 30, 2021 | 631.11B | 61.64% |
| Dec 30, 2020 | 390.43B | 47.64% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.43T |
| Celltrion | 41.00T |
| ALTEOGEN | 27.70T |
| SK Biopharmaceuticals | 10.10T |
| ABL Bio | 9.56T |
| Yuhan | 8.91T |
| Peptron | 7.43T |
| LigaChem Biosciences | 6.30T |